ArticleCancer research2025
Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma.
Ilango Balakrishnan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancer research2025
Ilango Balakrishnan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.